Bioceres Crop Solutions (BIOX) to Release Quarterly Earnings on Tuesday

Bioceres Crop Solutions (NASDAQ:BIOX) will likely be posting its Q3 2026 results before the market opens on Tuesday, May 12th. Analysts expect Bioceres Crop Solutions to post earnings of ($0.05) per share and revenue of $54.50 million for the quarter. Parties can check the company’s upcoming Q3 2026 earning summary page for the latest details on the call scheduled for Tuesday, May 12, 2026 at 8:30 AM ET.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings data on Friday, March 13th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.15). The firm had revenue of $73.67 million during the quarter, compared to the consensus estimate of $104.55 million. Bioceres Crop Solutions had a negative net margin of 82.83% and a negative return on equity of 22.43%.

Bioceres Crop Solutions Price Performance

Shares of NASDAQ:BIOX opened at $0.47 on Monday. The firm has a market capitalization of $29.73 million, a PE ratio of -0.13 and a beta of 0.39. The company has a quick ratio of 0.69, a current ratio of 0.90 and a debt-to-equity ratio of 0.32. The company has a 50-day moving average price of $0.51 and a two-hundred day moving average price of $1.05. Bioceres Crop Solutions has a twelve month low of $0.35 and a twelve month high of $5.18.

Analysts Set New Price Targets

Several research firms recently commented on BIOX. Weiss Ratings downgraded shares of Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a report on Wednesday. Wall Street Zen downgraded Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research report on Saturday, April 4th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $4.00.

Hedge Funds Weigh In On Bioceres Crop Solutions

A number of large investors have recently modified their holdings of BIOX. Marshall Wace LLP lifted its stake in Bioceres Crop Solutions by 180.0% in the 4th quarter. Marshall Wace LLP now owns 595,410 shares of the company’s stock worth $780,000 after purchasing an additional 382,744 shares in the last quarter. GAM Holding AG purchased a new position in shares of Bioceres Crop Solutions during the 4th quarter valued at $655,000. Susquehanna International Group LLP purchased a new position in shares of Bioceres Crop Solutions during the 3rd quarter valued at $315,000. State of Wisconsin Investment Board bought a new position in shares of Bioceres Crop Solutions in the fourth quarter worth $247,000. Finally, Squarepoint Ops LLC bought a new position in shares of Bioceres Crop Solutions in the third quarter worth $233,000. 17.68% of the stock is currently owned by institutional investors.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.